We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock
HARP

Delisted

HARP was delisted on the 8th of March, 2024.

Back to rankings

85 hedge funds and large institutions have $357M invested in Harpoon Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 28

3% less funds holding

Funds holding: 88 → 85 (-3)

18% less call options, than puts

Call options by funds: $1.54M | Put options by funds: $1.9M

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

36% less capital invested

Capital invested by funds: $562M → $357M (-$205M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
85
Holders Change
-3
Holders Change %
-3.41%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
10
Increased
39
Reduced
28
Closed
13
Calls
$1.54M
Puts
$1.9M
Net Calls
-$350K
Net Calls Change
+$570K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$21.4M
2
VA
VR Adviser
New York
+$9.77M
3
LGM
Logos Global Management
California
+$9.54M
4
CS
Candriam SCA
Luxembourg
+$9.34M
5
MS
Maven Securities
Jersey
+$9.32M

Top Sellers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
-$16.1M
2
MB
MPM BioImpact
Massachusetts
-$13.4M
3
UBS AM
UBS AM
Illinois
-$9.26M
4
FCM
Farallon Capital Management
California
-$5.23M
5
ACM
Altium Capital Management
New York
-$4.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.4M +$319K +1,672 +11%
Federated Hermes
27
Federated Hermes
Pennsylvania
$1.78M +$2.44M +12,808 +75,341%
B
28
Bailard
California
$1.65M -$227K -1,190 -9%
N
29
Nuveen
North Carolina
$1.64M +$397K +2,080 +21%
IC
30
Ikarian Capital
Texas
$1.58M -$2.96M -15,500 -58%
DCM
31
DAFNA Capital Management
California
$1.46M -$410K -2,150 -17%
Citigroup
32
Citigroup
New York
$1.45M +$1.75M +9,166 +705%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$1.31M +$1.24M +6,509 +221%
PAM
34
Panagora Asset Management
Massachusetts
$1.1M -$108K -567 -7%
Los Angeles Capital Management
35
Los Angeles Capital Management
California
$837K +$696K +3,647 +153%
SSA
36
Schonfeld Strategic Advisors
New York
$828K -$37.8K -198 -3%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$826K +$1.14M +5,955 New
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$749K +$1.03M +5,403 New
AAA
39
Affinity Asset Advisors
New York
$694K +$572K +3,000 +150%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$653K -$836K -4,381 -48%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$644K +$110K +576 +14%
Barclays
42
Barclays
United Kingdom
$500K +$363K +1,902 +111%
Citadel Advisors
43
Citadel Advisors
Florida
$368K -$5.34K -28 -1%
AllianceBernstein
44
AllianceBernstein
Tennessee
$362K +$206K +1,080 +71%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$359K +$103K +542 +27%
SO
46
STRS Ohio
Ohio
$355K +$242K +1,270 +98%
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$318K -$499K -2,614 -53%
IA
48
IndexIQ Advisors
New York
$268K -$21.6K -113 -6%
EGM
49
Engineers Gate Manager
New York
$253K +$348K +1,822 New
Deutsche Bank
50
Deutsche Bank
Germany
$251K +$48.8K +256 +16%
1
2
3 4

HARP Hedge Fund Activity: Q2 2021 in Review

85 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Harpoon Therapeutics, Inc. Common Stock (HARP) for Q2 2021, worth a combined $357M — down 36% from $562M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HARP and 10 opened new positions — a net loss of 3 holders — while 28 trimmed existing stakes and 39 added.

The largest buyer was State Street, adding an estimated $21.4M. The largest seller was Aquilo Capital Management, cutting an estimated $16.1M.

  • 85 institutional investors held Harpoon Therapeutics, Inc. Common Stock (HARP) as of Q2 2021, down from 88 in Q1 2021.
  • Funds reported $357M of Harpoon Therapeutics, Inc. Common Stock stock for Q2 2021, down 36% quarter-over-quarter.
  • 10 funds opened new Harpoon Therapeutics, Inc. Common Stock positions in Q2 2021 and 13 closed out, a net change of -3 holders.
  • The largest Harpoon Therapeutics, Inc. Common Stock buyer in Q2 2021 was State Street, an estimated $21.4M added.
  • The largest Harpoon Therapeutics, Inc. Common Stock seller in Q2 2021 was Aquilo Capital Management, an estimated $16.1M sold.

Based on aggregated 13F filings for Q2 2021.